Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: ResMed, Inc.

Market Cap 27.24B 23.76B 21.97B 20.64B 38.58B 2,569B 38.86B 261B 101B 1,263B 102B 100B 4,394B P/E 2026 *
17.8x
P/E 2027 * 16.1x
Enterprise Value 26.38B 23.01B 21.28B 19.99B 37.37B 2,488B 37.63B 253B 97.85B 1,223B 99.03B 96.9B 4,256B EV / Sales 2026 *
4.67x
EV / Sales 2027 * 4.21x
Free-Float
75.61%
Yield 2026 *
1.29%
Yield 2027 * 1.43%
1 day+1.26%
1 week-3.16%
Current month-1.02%
1 month-10.12%
3 months-16.53%
6 months-22.99%
Current year-21.69%
1 week 184.65
Extreme 184.65
197.41
1 month 180.26
Extreme 180.265
211.56
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 28/02/2013
Director of Finance/CFO 40 03/05/2026
Compliance Officer - 31/12/2017
Director TitleAgeSince
Director/Board Member 78 31/12/2004
Chairman 53 24/01/2023
Chairman 83 31/05/1989
Date Insider Type Main position Quantity % Market Cap.
06-07Fiscal year

Chief Executive Officer

14,973 0.0103%
05-31Tax

General Counsel

-269 0.0002%
05-06Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-3.16%-25.64%-13.00% 27.24B
+0.63%-1.01%+16.77%-11.91% 173B
+1.14%-1.04%-20.14%+24.08% 144B
-0.33%-1.63%-9.79%-25.12% 125B
+0.76%-3.45%-55.29%-16.19% 67.32B
+0.78%+2.64%+18.33%-4.95% 50.3B
-0.58%-1.16%-25.96%-32.99% 43.8B
+2.20%-2.14%+9.95%+7.53% 35.89B
-0.44%-0.03%+3.74%+35.01% 34.9B
+0.72%-5.51%-13.59%-21.94% 28.02B
Average +0.61%-1.87%-10.16%-5.95% 72.96B
Weighted average by Cap. +0.57%-1.89%-7.90%-5.48%

Financials

2026 *2027 *
Net sales 5.65B 4.93B 4.56B 4.28B 8B 533B 8.06B 54.1B 20.96B 262B 21.21B 20.76B 912B 6.1B 5.32B 4.92B 4.62B 8.63B 575B 8.69B 58.36B 22.61B 283B 22.88B 22.39B 983B
Net income 1.55B 1.35B 1.25B 1.17B 2.19B 146B 2.21B 14.83B 5.74B 71.78B 5.81B 5.69B 250B 1.7B 1.48B 1.37B 1.29B 2.41B 160B 2.43B 16.28B 6.31B 78.82B 6.38B 6.25B 274B
Net Debt -859M -749M -693M -651M -1.22B -81.02B -1.23B -8.23B -3.19B -39.82B -3.22B -3.16B -139B -1.58B -1.38B -1.27B -1.2B -2.23B -149B -2.25B -15.1B -5.85B -73.12B -5.92B -5.79B -254B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
18/06/26 188.63 $ +1.26% 3,884,969
17/06/26 186.29 $ -3.94% 1,873,182
16/06/26 193.94 $ +0.62% 1,092,000
15/06/26 192.74 $ -1.05% 1,523,766
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
188.63USD
Average target price
262.20USD
Spread / Average Target
+39.00%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!